Anatara Lifesciences Ltd (ANR.AX)
AUD 0.05
(0.0%)
AUD 0.05
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | -748.91 Thousand AUD | -2924.31% |
| 2023 | -24.76 Thousand AUD | -0.35% |
| 2022 | -24.67 Thousand AUD | -293.89% |
| 2021 | -6265.00 AUD | 61.08% |
| 2020 | -16.09 Thousand AUD | 85.74% |
| 2019 | -112.85 Thousand AUD | 85.52% |
| 2018 | -779.46 Thousand AUD | -149.04% |
| 2017 | 1.58 Million AUD | 1.28% |
| 2016 | 1.56 Million AUD | 1131.32% |
| 2015 | -152.18 Thousand AUD | 8.39% |
| 2014 | -166.11 Thousand AUD | -105.3% |
| 2013 | -80.91 Thousand AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 FY | -2463.00 AUD | 90.05% |
| 2024 Q4 | -683.86 Thousand AUD | 0.0% |
| 2024 Q2 | 270.96 Thousand AUD | 0.0% |
| 2023 FY | -24.76 Thousand AUD | -0.35% |
| 2023 Q4 | -407.79 Thousand AUD | 0.0% |
| 2023 Q2 | 383.03 Thousand AUD | 0.0% |
| 2022 Q2 | 306.88 Thousand AUD | 0.0% |
| 2022 FY | -24.67 Thousand AUD | -293.89% |
| 2022 Q4 | -331.56 Thousand AUD | 0.0% |
| 2021 Q4 | -688.53 Thousand AUD | 0.0% |
| 2021 Q2 | 682.27 Thousand AUD | 0.0% |
| 2021 FY | -6265.00 AUD | 61.08% |
| 2020 Q2 | 406.95 Thousand AUD | 0.0% |
| 2020 FY | -16.09 Thousand AUD | 85.74% |
| 2020 Q4 | -423.05 Thousand AUD | 0.0% |
| 2019 FY | -112.85 Thousand AUD | 85.52% |
| 2019 Q4 | 130.73 Thousand AUD | 0.0% |
| 2019 Q2 | 219.7 Thousand AUD | 0.0% |
| 2018 FY | -779.46 Thousand AUD | -149.04% |
| 2018 Q4 | -1.05 Million AUD | 0.0% |
| 2018 Q2 | 271.23 Thousand AUD | 0.0% |
| 2017 Q2 | 1.1 Million AUD | 0.0% |
| 2017 FY | 1.58 Million AUD | 1.28% |
| 2017 Q4 | 486.91 Thousand AUD | 0.0% |
| 2016 Q2 | -246.69 Thousand AUD | 0.0% |
| 2016 FY | 1.56 Million AUD | 1131.32% |
| 2016 Q4 | 1.81 Million AUD | 0.0% |
| 2015 Q2 | -66 Thousand AUD | 0.0% |
| 2015 FY | -152.18 Thousand AUD | 8.39% |
| 2015 Q4 | -86.17 Thousand AUD | 0.0% |
| 2014 Q3 | - AUD | 100.0% |
| 2014 Q2 | -58.28 Thousand AUD | 0.0% |
| 2014 FY | -166.11 Thousand AUD | -105.3% |
| 2014 Q4 | -107.83 Thousand AUD | 0.0% |
| 2013 FY | -80.91 Thousand AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 50.94 Million AUD | 101.47% |
| Zelira Therapeutics Limited | 10.28 Thousand AUD | 7382.283% |
| Biome Australia Limited | 7.66 Million AUD | 109.765% |
| Patrys Limited | 1.39 Million AUD | 153.718% |
| Orthocell Limited | 3.68 Million AUD | 120.304% |
| Imugene Limited | -5.83 Million AUD | 87.176% |
| Noxopharm Limited | -534.81 Thousand AUD | -40.033% |
| PYC Therapeutics Limited | 22.05 Million AUD | 103.395% |
| Chimeric Therapeutics Limited | 7.45 Million AUD | 110.047% |
| Prescient Therapeutics Limited | 3.71 Million AUD | 120.173% |
| Proteomics International Laboratories Limited | -1.12 Million AUD | 33.323% |
| Cynata Therapeutics Limited | 2.31 Million AUD | 132.341% |
| CSL Limited | 15.28 Billion AUD | 100.005% |
| Arovella Therapeutics Limited | -25.97 Thousand AUD | -2782.751% |
| Bio-Gene Technology Limited | -301.44 Thousand AUD | -148.437% |
| Clinuvel Pharmaceuticals Limited | 78.09 Million AUD | 100.959% |
| Starpharma Holdings Limited | 7.65 Million AUD | 109.781% |
| Nanollose Limited | -348.95 Thousand AUD | -114.617% |
| Memphasys Limited | 1606.00 AUD | 46732.005% |
| Invex Therapeutics Ltd | 1.21 Million AUD | 161.778% |
| NeuroScientific Biopharmaceuticals Limited | -91.33 Thousand AUD | -719.942% |
| Amplia Therapeutics Limited | 4.01 Million AUD | 118.673% |
| Botanix Pharmaceuticals Limited | -6.55 Million AUD | 88.569% |
| Island Pharmaceuticals Limited | 1.25 Million AUD | 159.837% |
| Race Oncology Limited | 1.38 Million AUD | 153.882% |
| Nyrada Inc. | -5164.07 AUD | -14402.321% |
| Telix Pharmaceuticals Limited | 308.5 Million AUD | 100.243% |
| Dimerix Limited | 583.47 Thousand AUD | 228.353% |
| PharmAust Limited | -1641.00 AUD | -45537.416% |
| Immutep Limited | 1.44 Million AUD | 151.867% |
| Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 106.508% |
| Alterity Therapeutics Limited | 3.8 Million AUD | 119.682% |
| BTC Health Limited | 16.36 Thousand AUD | 4677.689% |
| Acrux Limited | -1.28 Million AUD | 41.674% |
| Neuren Pharmaceuticals Limited | 205.17 Million AUD | 100.365% |
| Biotron Limited | -40.49 Thousand AUD | -1749.252% |
| Tissue Repair Ltd | 150.51 Thousand AUD | 597.578% |
| AdAlta Limited | 1.5 Million AUD | 149.665% |
| Radiopharm Theranostics Limited | -21.3 Million AUD | 96.485% |
| Hexima Limited | - AUD | Infinity% |
| AnteoTech Limited | 460.39 Thousand AUD | 262.666% |
| Paradigm Biopharmaceuticals Limited | 56.81 Thousand AUD | 1418.225% |
| Recce Pharmaceuticals Ltd | -366.76 Thousand AUD | -104.192% |
| Avecho Biotechnology Limited | -43.79 Thousand AUD | -1610.035% |
| Actinogen Medical Limited | 9.93 Million AUD | 107.541% |
| Immuron Limited | 3.33 Million AUD | 122.444% |
| Argenica Therapeutics Limited | 2.59 Million AUD | 128.827% |